Efficacy and Safety of DA-9401 on Improvement of Sperm Motility
NCT ID: NCT03258437
Last Updated: 2018-03-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
27 participants
INTERVENTIONAL
2016-04-12
2018-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Impact of Probiotics on Sperm Quality in Middle-aged Men
NCT06544278
Effect of Antioxidant Probiotic Administration on Seminal Quality and Reproductive Outcomes.
NCT04585984
Effect of Dietary DHA Supplementation on Sperm Quality
NCT01368484
Effect of Different Ingestion Doses of Celastrol on Human Sperm Motility
NCT05413226
Valuation of Variable Dose of Docosahexanoic Acid for the Improvement of the Parameters of Male Fertility
NCT02889341
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DA-9401
capsules (4cap/d, 2.16 g/d) for 12 weeks.
DA-9401
Placebo
Placebo for 12 weeks.
Placebo
Placebo for 12 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DA-9401
Placebo
Placebo for 12 weeks.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* sperm motility 40\~69%
Exclusion Criteria
* Participation in any other clinical trials within past 1 months
* intense constipation
20 Years
55 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Korean Society for Sexual Medicine and Andrology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Park Jong Kwan
Principal Investigator, Chonbuk National University Hospital, Urology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chonbuk National University Hospital of urology
Jeonju, Jeollabuk-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DA-9401-SM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.